Hi Psychic
This is from an interested bystander in reply to your Monitor results query.
GenomeWeb: Pacific Edge Bladder Cancer Recurrence Test Outperforms Others in Head-to-Head Comparison.
CxBladder Monitor Trial finished in 2016, follow the link and you will see there were
803 enrolled participants.
https://clinicaltrials.gov/ct2/show/...&draw=1&rank=1
If you follow this link:
https://www.cxbladder.com/nz/news/20...ad-comparison/
you will find the associated study, the researchers collected a total of 1,036 urine samples from
803 patients undergoing surveillance for urothelial carcinoma. Of these, 1,016 samples were directly assessed using Cxbladder Monitor, cytology, NMP22 Bladderchek, and NMP22 ELISA.